VZV IgG HT
Device
DiaSorin Inc.
Total Payments
$10,735
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $9,180 | 1 | 0 |
| 2022 | $1,555 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,735 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| VZV IgG HT Clinical Study | DiaSorin Inc. | $10,735 | 0 |
Top Doctors Receiving Payments for VZV IgG HT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Minneapolis, MN | $10,735 | 2 |
Ad
Manufacturing Companies
- DiaSorin Inc. $10,735
Product Information
- Type Device
- Total Payments $10,735
- Total Doctors 0
- Transactions 2
About VZV IgG HT
VZV IgG HT is a device associated with $10,735 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Inc..
Payment data is available from 2022 to 2023. In 2023, $9,180 was paid across 1 transactions to 0 doctors.
The most common payment nature for VZV IgG HT is "Unspecified" ($10,735, 100.0% of total).
VZV IgG HT is associated with 1 research study, including "VZV IgG HT Clinical Study" ($10,735).